CN101234131A - 一种板蓝根泡腾颗粒及其制备方法 - Google Patents
一种板蓝根泡腾颗粒及其制备方法 Download PDFInfo
- Publication number
- CN101234131A CN101234131A CNA2008101008363A CN200810100836A CN101234131A CN 101234131 A CN101234131 A CN 101234131A CN A2008101008363 A CNA2008101008363 A CN A2008101008363A CN 200810100836 A CN200810100836 A CN 200810100836A CN 101234131 A CN101234131 A CN 101234131A
- Authority
- CN
- China
- Prior art keywords
- radix isatidis
- effervescent granule
- alkaline matter
- macromolecular compound
- acidic materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 241000334160 Isatis Species 0.000 title abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 34
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 33
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 33
- 230000002378 acidificating effect Effects 0.000 claims abstract description 31
- 229920002521 macromolecule Polymers 0.000 claims abstract description 31
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 18
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract description 16
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims abstract description 16
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 16
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 14
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 13
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 12
- 239000008101 lactose Substances 0.000 claims abstract description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 11
- 235000015165 citric acid Nutrition 0.000 claims abstract description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 11
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 10
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 9
- 229920001353 Dextrin Polymers 0.000 claims abstract description 9
- 239000004375 Dextrin Substances 0.000 claims abstract description 9
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 9
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 9
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019425 dextrin Nutrition 0.000 claims abstract description 9
- 235000011090 malic acid Nutrition 0.000 claims abstract description 9
- 239000001630 malic acid Substances 0.000 claims abstract description 9
- 239000011780 sodium chloride Substances 0.000 claims abstract description 9
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 9
- 239000011975 tartaric acid Substances 0.000 claims abstract description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract description 8
- 229930195725 Mannitol Natural products 0.000 claims abstract description 8
- 229920002472 Starch Polymers 0.000 claims abstract description 8
- 239000001361 adipic acid Substances 0.000 claims abstract description 8
- 235000011037 adipic acid Nutrition 0.000 claims abstract description 8
- 239000001530 fumaric acid Substances 0.000 claims abstract description 8
- 235000011087 fumaric acid Nutrition 0.000 claims abstract description 8
- 239000000594 mannitol Substances 0.000 claims abstract description 8
- 235000010355 mannitol Nutrition 0.000 claims abstract description 8
- 239000011736 potassium bicarbonate Substances 0.000 claims abstract description 8
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims abstract description 8
- 235000015497 potassium bicarbonate Nutrition 0.000 claims abstract description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 claims abstract description 8
- 235000011181 potassium carbonates Nutrition 0.000 claims abstract description 8
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims abstract description 8
- 235000017550 sodium carbonate Nutrition 0.000 claims abstract description 8
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 8
- 239000008107 starch Substances 0.000 claims abstract description 8
- 235000019698 starch Nutrition 0.000 claims abstract description 8
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000010231 banlangen Substances 0.000 claims description 70
- 239000000203 mixture Substances 0.000 claims description 21
- 238000005303 weighing Methods 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 238000012856 packing Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 230000001476 alcoholic effect Effects 0.000 claims description 10
- 239000011230 binding agent Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000000080 wetting agent Substances 0.000 claims description 7
- 229940095686 granule product Drugs 0.000 claims description 6
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims description 6
- 230000004927 fusion Effects 0.000 claims description 4
- 239000008202 granule composition Substances 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 3
- -1 remix is even Substances 0.000 claims description 2
- 229920005606 polypropylene copolymer Polymers 0.000 abstract 1
- 239000002253 acid Substances 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 210000003026 hypopharynx Anatomy 0.000 description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 4
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000008118 PEG 6000 Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 101100027969 Caenorhabditis elegans old-1 gene Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 239000004518 granules dosage form Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008101008363A CN101234131A (zh) | 2008-02-22 | 2008-02-22 | 一种板蓝根泡腾颗粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008101008363A CN101234131A (zh) | 2008-02-22 | 2008-02-22 | 一种板蓝根泡腾颗粒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101234131A true CN101234131A (zh) | 2008-08-06 |
Family
ID=39918198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008101008363A Pending CN101234131A (zh) | 2008-02-22 | 2008-02-22 | 一种板蓝根泡腾颗粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101234131A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105343012A (zh) * | 2015-11-19 | 2016-02-24 | 泰山医学院 | 杜仲多糖泡腾颗粒及其制备方法 |
CN108084989A (zh) * | 2017-12-25 | 2018-05-29 | 中国石油天然气股份有限公司 | 一种用于滑溜水压裂的泡腾气悬浮支撑剂及其制备方法 |
-
2008
- 2008-02-22 CN CNA2008101008363A patent/CN101234131A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105343012A (zh) * | 2015-11-19 | 2016-02-24 | 泰山医学院 | 杜仲多糖泡腾颗粒及其制备方法 |
CN108084989A (zh) * | 2017-12-25 | 2018-05-29 | 中国石油天然气股份有限公司 | 一种用于滑溜水压裂的泡腾气悬浮支撑剂及其制备方法 |
CN108084989B (zh) * | 2017-12-25 | 2021-03-30 | 中国石油天然气股份有限公司 | 一种用于滑溜水压裂的泡腾气悬浮支撑剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101919801B (zh) | 口腔吸收固体能量泡腾制剂 | |
WO2018077310A1 (zh) | 一种含维生素c钠的泡腾片及其制备方法 | |
CN103751192A (zh) | 包含利拉列汀和任选的sglt2抑制剂的药物组合物及其用途 | |
CN102387783A (zh) | 包含吡喃葡萄糖基二苯基甲烷衍生物的药物组合物、其药物剂型、其制备方法及其在患者中改善血糖控制的用途 | |
CN101500568A (zh) | 匹莫范色林的药物制剂 | |
AU2018203085B2 (en) | Effervescent composition and method of making it | |
EP2005945A9 (en) | Oseltamivir phosphate granule and preparation mehtod thereof | |
CN100546571C (zh) | 桑菊感冒泡腾片 | |
CN107137373B (zh) | 一种茶多酚泡腾片及其制备方法 | |
CN101744852B (zh) | 刺五加泡腾片的制备方法及其产品 | |
CN101234131A (zh) | 一种板蓝根泡腾颗粒及其制备方法 | |
KR20160021547A (ko) | 민들레 추출물을 포함하는 발포정 조성물 및 그의 제조방법 | |
CN108024968B (zh) | 门冬氨酸鸟氨酸的泡腾制剂 | |
CN111803452A (zh) | 一种包含盐酸去氧肾上腺素组合物的泡腾颗粒剂制备工艺 | |
CN105708808B (zh) | 一种盐酸依匹斯汀颗粒剂及其制备方法 | |
CN100448431C (zh) | 一种用于治疗儿童感冒的氨酚麻美口腔崩解片及制备方法 | |
CN101647781A (zh) | 注射用磷酸川芎嗪粉针的制备方法 | |
CN102210453A (zh) | 泡腾口香糖及其制备方法 | |
CN100546570C (zh) | 感冒清热泡腾片 | |
CN100536829C (zh) | 灯盏花口腔快速崩解片及其制备方法 | |
CN101264129A (zh) | 一种无糖益心香青兰颗粒剂 | |
CN104382882A (zh) | 一种非pH依赖性的扎来普隆双脉冲释放胶囊及其制备方法 | |
JP4281281B2 (ja) | 分岐鎖アミノ酸を含有するドライシロップ剤 | |
CN106581096A (zh) | 马齿苋抗氧化泡腾片的制备方法 | |
CN100542522C (zh) | 抗病毒泡腾片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080718 Address after: Luolang road Guangzhou economic and Technological Development Zone No. 33 Applicant after: Guangzhou Xiangxue Pharmaceutical Co., ltd. Address before: Beijing city of Ayutthaya road laqiying District 1 building 602 Applicant before: Wang Yiming |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Guangzhou Xiangxue Pharmaceutical Co., ltd. Zhong Wangqin Document name: Notification that Application Deemed to be Withdrawn |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20080806 |